Bioxytran Inc (BIXT)

$0.07 +0.00 (1.45%)
Market Cap 6.23M
Revenue (ttm) 0.00
Net Income (ttm) -2.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.02
Volume 8,100
Avg Vol 83,674
Day's Range N/A - N/A
Shares Out 88.99M
Stochastic %K 48%
Beta 1.35
Analysts Strong Buy
Price Target N/A

Company Profile

Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLec...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 454 1199
Address:
75 2nd Avenue, Ste 605, Needham, United States
History101
History101 Oct. 2 at 6:48 PM
$BIXT added under 7 cents...
0 · Reply
History101
History101 Sep. 23 at 6:19 PM
$BIXT got a buy order in for 0.068
0 · Reply
History101
History101 Sep. 18 at 6:02 PM
$BIXT added
0 · Reply
History101
History101 Sep. 16 at 3:23 PM
$BIXT wow, 11:20am eastern and not a single share traded...
0 · Reply
History101
History101 Sep. 12 at 6:35 PM
$BIXT still over 1.5 hours of trading left, and BIXT at over 2x normal avg volume...
0 · Reply
History101
History101 Sep. 12 at 5:10 PM
$RADX my biotechs are all in the red today, except for RADX, $BIXT & $CAMP....GLTALS!!
0 · Reply
History101
History101 Sep. 12 at 4:55 PM
$GALT practically every biotech I own today, with the notable exceptions of $BIXT & $CAMP, is red by a couple %, so this isn't just a GALT/$CGTX thing....
1 · Reply
History101
History101 Sep. 12 at 3:59 PM
$BIXT as of noon est., nearly 2x avg volume, share price up 13%...GLTALs!!
0 · Reply
History101
History101 Sep. 11 at 9:55 PM
$BIXT 250 watching 9/11/2025
0 · Reply
History101
History101 Sep. 11 at 2:46 PM
$BIXT very nice now that my position is up more than 11%, now I just wait for the accelerated approval voucher from RFK Jr's FDA...GLTALs!!
0 · Reply
Latest News on BIXT
No data available.
History101
History101 Oct. 2 at 6:48 PM
$BIXT added under 7 cents...
0 · Reply
History101
History101 Sep. 23 at 6:19 PM
$BIXT got a buy order in for 0.068
0 · Reply
History101
History101 Sep. 18 at 6:02 PM
$BIXT added
0 · Reply
History101
History101 Sep. 16 at 3:23 PM
$BIXT wow, 11:20am eastern and not a single share traded...
0 · Reply
History101
History101 Sep. 12 at 6:35 PM
$BIXT still over 1.5 hours of trading left, and BIXT at over 2x normal avg volume...
0 · Reply
History101
History101 Sep. 12 at 5:10 PM
$RADX my biotechs are all in the red today, except for RADX, $BIXT & $CAMP....GLTALS!!
0 · Reply
History101
History101 Sep. 12 at 4:55 PM
$GALT practically every biotech I own today, with the notable exceptions of $BIXT & $CAMP, is red by a couple %, so this isn't just a GALT/$CGTX thing....
1 · Reply
History101
History101 Sep. 12 at 3:59 PM
$BIXT as of noon est., nearly 2x avg volume, share price up 13%...GLTALs!!
0 · Reply
History101
History101 Sep. 11 at 9:55 PM
$BIXT 250 watching 9/11/2025
0 · Reply
History101
History101 Sep. 11 at 2:46 PM
$BIXT very nice now that my position is up more than 11%, now I just wait for the accelerated approval voucher from RFK Jr's FDA...GLTALs!!
0 · Reply
History101
History101 Aug. 26 at 5:45 PM
$BIXT volume so far today is 10.4k shares traded. I am 10k of that. LOL....
0 · Reply
History101
History101 Aug. 18 at 5:56 PM
$BIXT my position cost basis now = $0.0784...GLTALs!!
1 · Reply
History101
History101 Aug. 18 at 2:38 AM
$BIXT accelerated approvals already happening: https://www.zerohedge.com/medical/fda-approves-therapy-rare-disease-without-randomized-trial-data
0 · Reply
History101
History101 Aug. 13 at 3:52 PM
$BIXT averaged down, now position cost basis $0.081
0 · Reply
History101
History101 Aug. 13 at 2:44 PM
$GALT GALT should buy $BIXT
1 · Reply
History101
History101 Aug. 12 at 5:45 PM
$BIXT 248 watching 8/12/2025
1 · Reply
History101
History101 Aug. 12 at 5:16 PM
$BIXT added today, position cost basis now $0.083....GLTALs!!
0 · Reply
BCE_TechMaster
BCE_TechMaster Jul. 29 at 3:12 PM
$BIXT https://biotuesdays.com/2025/07/29/bioxytran-disrupting-infectious-disease-and-inflammation-with-carbohydrate-based-therapeutics/ Bounce has started. Twitter X is hopping all over this with posts and the L-2 is super thin to .25/share, and easy double
0 · Reply
Zardiw
Zardiw Jul. 29 at 3:05 PM
$BIXT: Bioxytran disrupting infectious disease and inflammation with carbohydrate-based therapeutics: https://biotuesdays.com/2025/07/29/bioxytran-disrupting-infectious-disease-and-inflammation-with-carbohydrate-based-therapeutics/ Z
0 · Reply
History101
History101 Jul. 23 at 11:48 PM
$BIXT "The other three priorities are unchanged from the June notice, but the FDA has provided new examples. The agency named “a universal flu vaccine that could provide broad protection against multiple strains of influenza, including those with pandemic potential,” as an example of a product that could address a U.S. public health crisis."
0 · Reply
History101
History101 Jul. 23 at 8:05 PM
$BIXT BIXT management needs to get on this asap: "FDA officials plan to pick up to five companies to participate in the pilot in the first year of the program. To accelerate reviews, the FDA will convene a senior, multidisciplinary review committee led by its Office of the Chief Medical and Scientific Officer. The FDA contrasted the model to its standard approach of sending applications to numerous offices staffed by reviewers who are “juggling competing priorities.”" https://www.fiercebiotech.com/biotech/fda-opens-national-priority-fast-track-offering-2-month-reviews-onshoring-and-affordability
0 · Reply
History101
History101 Jul. 22 at 8:16 PM
$BIXT 248 watching 7/22/2025
0 · Reply